Designed for specialist prescribers and clinicians, this advanced module evaluates the evolving evidence base for medical cannabis across a spectrum of psychiatric disorders.
You will examine the role of the Endocannabinoid System (ECS) in mood regulation, fear extinction, and stress response, and critically appraise the data—ranging from preclinical rationale to emerging Real-World Evidence (RWE) for conditions including anxiety, depression, PTSD, and neurodevelopmental disorders.
The course provides specific, evidence-based prescribing protocols for patient selection, risk stratification (specifically regarding psychosis history), and the management of complex cases.
By the end of this course you will be able to:
The Biological Rationale
Regulatory Landscape & Safety
Evidence: Common vs. Neurodevelopmental Conditions
Challenges in Research & Stigma
Defining Anxiety Disorders
Biological Mechanisms (Amygdala & HPA Axis)
Evidence Base: RCTs vs. Real-World Data
Safety & Adverse Events
Pathophysiology of Depression
Biological Mechanisms & Neurogenesis
The Evidence Base
Safety & Research Gaps
Defining the Problem
The Biological Rationale
Evidence & Prescribing
Safety Profile & Considerations
Diagnostic Criteria & Symptom Clusters
ECS and Fear Extinction
The Evidence Gap (RCTs vs. RWE)
Real-World Evidence
Prevalence, Incidence & Diagnosis
The Clinical Picture & Treatment Goals
The Biological Rationale
The Evidence Landscape
The Clinical Picture (Adult vs. Paediatric)
Neurobiology and Clinical Evidence
Registry Data in Detail
Prescribing & Safety
Sublingual/Oral Prescribing
Inhaled Prescribing
Safety: Contraindications (Psychosis Risk)
Drug-Drug Interactions & Monitoring
Alongside this course, the Foundations of Medical Cannabis pathway includes additional courses that expand on history, biology, and clinical practice. Each is short, [[CPD_ACCREDITED_COMMA]] and designed to build confidence step by step.
